精華制藥(yao)集(ji)團股(gu)份有限公(gong)司是由(you)南(nan)通(tong)(tong)產控(kong)集(ji)團控(kong)股(gu)、國(guo)資(zi)(zi)監管的地方國(guo)有控(kong)股(gu)企(qi)業,由(you)原南(nan)通(tong)(tong)中(zhong)誠制藥(yao)有限公(gong)司(南(nan)通(tong)(tong)中(zhong)藥(yao)廠)變更、重(zhong)組南(nan)通(tong)(tong)制藥(yao)總(zong)廠(南(nan)通(tong)(tong)制藥(yao)廠、南(nan)通(tong)(tong)制藥(yao)二廠)優(you)質資(zi)(zi)源,并吸收民營資(zi)(zi)本南(nan)通(tong)(tong)綜藝(yi)投(tou)資(zi)(zi)有限公(gong)司以(yi)及自然(ran)人投(tou)資(zi)(zi)設立。2010年2月在深(shen)交所(suo)中(zhong)小板掛牌上(shang)市(shi),股(gu)票(piao)簡稱:精華制藥(yao),證券代號:002349。
公(gong)司(si)(si)已(yi)有(you)60多年的(de)(de)制(zhi)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)歷(li)史(shi),是一家(jia)(jia)綜合(he)性的(de)(de)現代化(hua)(hua)GMP制(zhi)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)有(you)限公(gong)司(si)(si)。目前擁有(you)7個(ge)(ge)(ge)子公(gong)司(si)(si),是一家(jia)(jia)集中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)制(zhi)劑(ji)、中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)飲片(pian)(pian)、西藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)制(zhi)劑(ji)、醫(yi)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)中(zhong)(zhong)(zhong)間(jian)體(ti)、化(hua)(hua)學原(yuan)料藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)、生物制(zhi)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)、保(bao)(bao)(bao)健品(pin)等(deng)(deng)生產(chan)、銷售和研(yan)發的(de)(de)綜合(he)型(xing)制(zhi)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)企業集團。公(gong)司(si)(si)有(you)中(zhong)(zhong)(zhong)西藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)品(pin)種(zhong)(zhong)(zhong)200余種(zhong)(zhong)(zhong),中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)產(chan)品(pin)主(zhu)要有(you)享譽海內外的(de)(de)經典名(ming)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)“五朵金(jin)花”王(wang)氏保(bao)(bao)(bao)赤(chi)(chi)丸、季(ji)德勝(sheng)(sheng)蛇藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)片(pian)(pian)、正柴(chai)胡(hu)飲顆粒、大柴(chai)胡(hu)顆粒、金(jin)蕎麥膠(jiao)囊,以(yi)及固本咳喘片(pian)(pian)、暈(yun)可平(ping)糖漿、精血補片(pian)(pian)等(deng)(deng),這些中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)品(pin)種(zhong)(zhong)(zhong)都有(you)著廣泛的(de)(de)歷(li)史(shi)背景及深厚的(de)(de)文(wen)化(hua)(hua)底蘊,其(qi)(qi)中(zhong)(zhong)(zhong)季(ji)德勝(sheng)(sheng)蛇藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)片(pian)(pian)、王(wang)氏保(bao)(bao)(bao)赤(chi)(chi)丸制(zhi)作技藝均被列(lie)入(ru)國家(jia)(jia)非(fei)物質文(wen)化(hua)(hua)遺產(chan)。原(yuan)料藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)產(chan)品(pin)主(zhu)要有(you)苯巴(ba)比妥、撲米酮、氟尿嘧(mi)啶(ding)(ding)(ding)、保(bao)(bao)(bao)泰松、氟胞嘧(mi)啶(ding)(ding)(ding)、吡羅(luo)昔(xi)康、替(ti)諾昔(xi)康、丙(bing)硫氧嘧(mi)啶(ding)(ding)(ding)、非(fei)那西丁(ding)、雙嘧(mi)達莫以(yi)及其(qi)(qi)它醫(yi)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)中(zhong)(zhong)(zhong)間(jian)體(ti)等(deng)(deng)。其(qi)(qi)中(zhong)(zhong)(zhong)已(yi)有(you)10個(ge)(ge)(ge)品(pin)種(zhong)(zhong)(zhong)通(tong)(tong)過國家(jia)(jia)GMP認(ren)證,5個(ge)(ge)(ge)品(pin)種(zhong)(zhong)(zhong)通(tong)(tong)過歐盟(meng)CEP認(ren)證,2個(ge)(ge)(ge)品(pin)種(zhong)(zhong)(zhong)通(tong)(tong)過澳大利亞GMP認(ren)證,3個(ge)(ge)(ge)品(pin)種(zhong)(zhong)(zhong)通(tong)(tong)過墨西哥(ge)官方(fang)認(ren)證,4個(ge)(ge)(ge)品(pin)種(zhong)(zhong)(zhong)獲得(de)美國DMF注冊文(wen)件(jian)(jian) ,1個(ge)(ge)(ge)品(pin)種(zhong)(zhong)(zhong)獲得(de)美國VMF注冊文(wen)件(jian)(jian),并已(yi)通(tong)(tong)過美國FDA現場(chang)核查。
精(jing)華制藥(yao)(yao)將會(hui)以“成為以傳世(shi)中藥(yao)(yao)為核(he)心特(te)色(se)的(de)全國現代醫(yi)藥(yao)(yao)企業(ye)”為戰略(lve)(lve)目標,深入貫徹(che)《關于促進(jin)中醫(yi)藥(yao)(yao)傳承創(chuang)新發展的(de)意見》精(jing)神(shen),聚焦“五朵金花”傳世(shi)中藥(yao)(yao)主業(ye)為主,特(te)色(se)化(hua)學原料藥(yao)(yao)及(ji)化(hua)學制劑(ji)為輔的(de)“雙輪驅(qu)動”的(de)發展戰略(lve)(lve),依(yi)托(tuo)品牌力(li)和渠道(dao)力(li),致力(li)于成為以傳世(shi)中藥(yao)(yao)為核(he)心特(te)色(se)的(de)全國現代醫(yi)藥(yao)(yao)企業(ye)。